Motor changes precede the emergence of cognitive impairment (CI), and Alzheimer's disease is the most common type of CI.
Objective
The study aimed to investigate the characteristics of surface electromyography (sEMG) in patients with CI and explore the ability of sEMG for CI detection.
Methods
639 participants were enrolled, including 284 patients with CI, and 355 controls. A series of motor and cognitive assessment were conducted. The sEMG examination under single and dual-task patterns were performed.
Results
The CI group exhibited significantly decreased motor function, including muscle bulk, swallowing, balance, and gait. Significant alterations of 20 sEMG features were detected in CI group compared to controls (p < 0.05), among them, the integrated electromyography feature of right gastrocnemius lateralis in dual-task was positively associated with plasma p-tau181 (r = 0.21, p = 0.017). Besides, the distinctive sEMG features were significantly correlated with cognitive scores (p < 0.05). Furthermore, the combination of single and dual-task sEMG model can effectively distinguish CI from controls with an area under the curve (AUC) of 0.849, and the AUC reached 0.948 after combining with p-tau181.
Conclusions
Motor dysfunction is common in patients with CI, and sEMG can serve as an effective tool for CI screening.
LivingstonGHuntleyJLiuKY, et al.Dementia prevention, intervention, and care: 2024 report of the lancet standing commission. Lancet2024; 404: 572–628.
2.
JiaJWangFWeiC, et al.The prevalence of dementia in urban and rural areas of China. Alzheimers Dement2014; 10: 1–9.
3.
DrewL. An age-old story of dementia. Nature2018; 559: S2–s3.
4.
XiaoXLiuHYaoR, et al.LMTK2 And CRB1 are two novel risk genes for Alzheimer's disease in Han Chinese. J Prev Alzheimers Dis2025; 12: 100087.
5.
OveisgharanSWangTBarnesLL, et al.The time course of motor and cognitive decline in older adults and their associations with brain pathologies: a multicohort study. Lancet Healthy Longev2024; 5: e336–e345.
6.
CamicioliRHowiesonDOkenB, et al.Motor slowing precedes cognitive impairment in the oldest old. Neurology1998; 50: 1496–1498.
7.
BuracchioTDodgeHHHowiesonD, et al.The trajectory of gait speed preceding mild cognitive impairment. Arch Neurol2010; 67: 980–986.
8.
WilkinsCHRoeCMMorrisJC, et al.Mild physical impairment predicts future diagnosis of dementia of the Alzheimer's type. J Am Geriatr Soc2013; 61: 1055–1059.
9.
KuoKZhangYRChenSD, et al.Associations of grip strength, walking pace, and the risk of incident dementia: a prospective cohort study of 340212 participants. Alzheimers Dement2023; 19: 1415–1427.
10.
NadkarniNKPereraSSnitzBE, et al.Association of brain amyloid-β with slow gait in elderly individuals without dementia: influence of cognition and apolipoprotein E ε4 genotype. JAMA Neurol2017; 74: 82–90.
11.
MakhnevichAPerrinATalukderD, et al.Thick liquids and clinical outcomes in hospitalized patients with Alzheimer disease and related dementias and dysphagia. JAMA Intern Med2024; 184: 778–785.
12.
DuchownyKAAckleySFBrenowitzWD, et al.Associations between handgrip strength and dementia risk, cognition, and neuroimaging outcomes in the UK biobank cohort study. JAMA Netw Open2022; 5: e2218314.
13.
ChouMYNishitaYNakagawaT, et al.Role of gait speed and grip strength in predicting 10-year cognitive decline among community-dwelling older people. BMC Geriatr2019; 19: 186.
14.
KwakKKosticEKimD. Gait variability-based classification of the stages of the cognitive decline using partial least squares-discriminant analysis. Sci Prog2023; 106: 368504231218604.
15.
LinJXuTYangX, et al.A detection model of cognitive impairment via the integrated gait and eye movement analysis from a large Chinese community cohort. Alzheimers Dement2024; 20: 1089–1101.
16.
PullmanSLGoodinDSMarquinezAI, et al.Clinical utility of surface EMG: report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology2000; 55: 171–177.
17.
AlcanVZinnuroğluM. Current developments in surface electromyography. Turk J Med Sci2023; 53: 1019–1031.
18.
Sande de SouzaLADionísioVCAlmeidaGL. Multi-joint movements with reversal in Parkinson's disease: kinematics and electromyography. J Electromyogr Kinesiol2011; 21: 376–383.
19.
SiYHeRJiangL, et al.Differentiating between Alzheimer's disease and frontotemporal dementia based on the resting-state multilayer EEG network. IEEE Trans Neural Syst Rehabil Eng2023; 31: 4521–4527.
20.
TăuƫanAMCasulaEPPellicciariMC, et al.TMS-EEG perturbation biomarkers for Alzheimer's disease patients classification. Sci Rep2023; 13: 7667.
21.
KochGMartoranaACaltagironeC. Transcranial magnetic stimulation: emerging biomarkers and novel therapeutics in Alzheimer's disease. Neurosci Lett2020; 719: 134355.
22.
XuTBuGYuanL, et al.The prevalence and risk factors study of cognitive impairment: analysis of the elderly population of han nationality in hunan province, China. CNS Neurosci Ther2024; 30: e14478.
23.
KatzmanRZhangMYOuang YaQ, et al.A Chinese version of the Mini-mental state examination; impact of illiteracy in a Shanghai dementia survey. J Clin Epidemiol1988; 41: 971–978.
24.
LangaKMLevineDA. The diagnosis and management of mild cognitive impairment: a clinical review. JAMA2014; 312: 2551–2561.
25.
JiaoBZhangSBeiY, et al.A detection model for cognitive dysfunction based on volatile organic compounds from a large Chinese community cohort. Alzheimers Dement2023; 19: 4852–4862.
26.
ChenLKWooJAssantachaiP, et al.Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc2020; 21: 300–307.e302.
27.
YangCMoYCaoX, et al.Reliability and validity of the Tinetti performance oriented mobility assessment in Chinese community-dwelling older adults. Geriatr Nurs2023; 53: 85–89.
28.
NishikawaHAsaiAFukunishiS, et al.Screening tools for sarcopenia. In Vivo2021; 35: 3001–3009.
29.
LongstaffMGHeathRA. Spiral drawing performance as an indicator of fine motor function in people with multiple sclerosis. Hum Mov Sci2006; 25: 474–491.
30.
MemediMWestinJNyholmD. Spiral drawing during self-rated dyskinesia is more impaired than during self-rated Off. Parkinsonism Relat Disord2013; 19: 553–556.
31.
OsawaAMaeshimaSTanahashiN. Water-swallowing test: screening for aspiration in stroke patients. Cerebrovasc Dis2013; 35: 276–281.
32.
TinettiME. Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc1986; 34: 119–126.
33.
Montero-OdassoMMuirSWSpeechleyM. Dual-task complexity affects gait in people with mild cognitive impairment: the interplay between gait variability, dual tasking, and risk of falls. Arch Phys Med Rehabil2012; 93: 293–299.
34.
JanelidzeSMattssonNPalmqvistS, et al.Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia. Nat Med2020; 26: 379–386.
35.
XuTWengLZhangC, et al.Genetic spectrum features and diagnostic accuracy of four plasma biomarkers in 248 Chinese patients with frontotemporal dementia. Alzheimers Dement2024; 20: 7281–7295.
36.
GonzalezMCAshtonNJGomesBF, et al.Association of plasma p-tau181 and p-tau231 concentrations with cognitive decline in patients with probable dementia with Lewy bodies. JAMA Neurol2022; 79: 32–37.
37.
YangYXiaoMLengL, et al.A systematic review and meta-analysis of the prevalence and correlation of mild cognitive impairment in sarcopenia. J Cachexia Sarcopenia Muscle2023; 14: 45–56.
38.
AminiNIbn HachMLapauwL, et al.Meta-analysis on the interrelationship between sarcopenia and mild cognitive impairment, Alzheimer's disease and other forms of dementia. J Cachexia Sarcopenia Muscle2024; 15: 1240–1253.
DarweeshSKLLicherSWoltersFJ, et al.Quantitative gait, cognitive decline, and incident dementia: the Rotterdam study. Alzheimers Dement2019; 15: 1264–1273.
41.
CeïdeMEAyersEILiptonR, et al.Walking while talking and risk of incident dementia. Am J Geriatr Psychiatry2018; 26: 580–588.
42.
HausdorffJMRiosDAEdelbergHK. Gait variability and fall risk in community-living older adults: a 1-year prospective study. Arch Phys Med Rehabil2001; 82: 1050–1056.
43.
Pieruccini-FariaFBlackSEMasellisM, et al.Gait variability across neurodegenerative and cognitive disorders: results from the Canadian consortium of neurodegeneration in aging (CCNA) and the gait and brain study. Alzheimers Dement2021; 17: 1317–1328.
44.
TianQChastanNBairWN, et al.The brain map of gait variability in aging, cognitive impairment and dementia-A systematic review. Neurosci Biobehav Rev2017; 74: 149–162.
45.
ObermanLMBenussiA. Transcranial magnetic stimulation across the lifespan: impact of developmental and degenerative processes. Biol Psychiatry2024; 95: 581–591.
46.
MarinelliLTrompettoCPuceL, et al.Electromyographic patterns of paratonia in normal subjects and in patients with mild cognitive impairment or Alzheimer's disease. J Alzheimers Dis2022; 87: 1065–1077.
47.
DrenthHZuidemaSBautmansI, et al.Paratonia in dementia: a systematic review. J Alzheimers Dis2020; 78: 1615–1637.
48.
BuchmanASSchneiderJALeurgansS, et al.Physical frailty in older persons is associated with Alzheimer disease pathology. Neurology2008; 71: 499–504.
49.
BrickmanAMManlyJJHonigLS, et al.Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study. Alzheimers Dement2021; 17: 1353–1364.
50.
RosliRTanMPGrayWK, et al.Cognitive assessment tools in Asia: a systematic review. Int Psychogeriatr2016; 28: 189–210.
51.
JiaoBLiRZhouH, et al.Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer's disease using EEG technology. Alzheimers Res Ther2023; 15: 32.
52.
VucicSStanley ChenKHKiernanMC, et al.Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee. Clin Neurophysiol2023; 150: 131–175.
53.
AlbersMWGilmoreGCKayeJ, et al.At the interface of sensory and motor dysfunctions and Alzheimer's disease. Alzheimers Dement2015; 11: 70–98.
54.
SuchowerskyOReichSPerlmutterJ, et al.Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the quality standards subcommittee of the American academy of neurology. Neurology2006; 66: 968–975.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
